Timing of blood thinners before hip surgery after heart stent
Part of Bones, joints & muscles, Heart & circulation, Injuries & trauma clinical trials.
This study looks at whether stopping blood thinners before hip surgery (within 6 weeks after a heart stent) is safe or if waiting longer is better. It compares heart risks when blood thinners are stopped early versus after 6 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning hip fracture surgery
- You have had a heart stent placed (PCI) and are taking two blood-thinning medicines (DAPT)
- You are between 20 and 28 on the BMI scale
- You have normal heart blood test results (hs-cTnI) before surgery
- You have not had other major surgeries or organ problems
- You do not have conditions like diabetes, kidney problems, or weak heart pumping that increase risk
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a way to shorten the time you need to take blood thinners after getting a specific type of heart stent. It uses a special camera (OCT) inside the artery to help decide if stents are placed well enough to allow less time on dual antiplatelet therapy.
This study tests whether a shorter course of blood-thinning medication after heart stent placement is safer and just as effective for older adults. It aims to reduce bleeding risks while still preventing heart attacks and strokes.
This study compares two ways to manage blood thinners after a stent. It tests whether switching from stronger drugs (prasugrel or ticagrelor) to clopidogrel is safe and effective for long-term heart protection.
This study is comparing two durations of antiplatelet therapy (blood thinners) after getting a heart stent, using ultrasound guidance to tailor the treatment. The goal is to find a shorter, safer medication plan that still prevents blood clots and heart attacks.
This trial looks at whether using heart imaging (OCT or angiogram) to guide how long you take two blood thinners after a heart attack (STEMI) can be safe and effective. If you qualify, your doctor may be able to reduce your blood thinner use sooner, which could lower bleeding risk while still protecting your heart.
This trial tests a new way of taking blood thinners after getting a stent. Instead of staying on two blood thinners for a long time, you switch earlier to just one (ticagrelor). This might reduce bleeding risks while still protecting against heart problems.
Hear when a new PCI Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.